1. Home
  2. SPXC vs GRFS Comparison

SPXC vs GRFS Comparison

Compare SPXC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPX Technologies Inc.

SPXC

SPX Technologies Inc.

HOLD

Current Price

$203.34

Market Cap

9.1B

Sector

Industrials

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.29

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPXC
GRFS
Founded
1912
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
6.2B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
SPXC
GRFS
Price
$203.34
$9.29
Analyst Decision
Buy
Hold
Analyst Count
7
2
Target Price
$214.14
$10.15
AVG Volume (30 Days)
732.2K
436.9K
Earning Date
10-30-2025
07-28-2022
Dividend Yield
N/A
1.54%
EPS Growth
26.00
N/A
EPS
4.69
0.64
Revenue
$2,161,500,000.00
$8,821,017,248.00
Revenue This Year
$16.13
$5.36
Revenue Next Year
$8.81
$5.15
P/E Ratio
$43.26
$18.21
Revenue Growth
12.60
7.31
52 Week Low
$115.00
$6.19
52 Week High
$233.71
$11.14

Technical Indicators

Market Signals
Indicator
SPXC
GRFS
Relative Strength Index (RSI) 44.80 60.46
Support Level $203.04 $9.04
Resistance Level $209.31 $9.24
Average True Range (ATR) 5.96 0.19
MACD -1.31 0.04
Stochastic Oscillator 24.01 77.27

Price Performance

Historical Comparison
SPXC
GRFS

About SPXC SPX Technologies Inc.

SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: